The tyrosine kinase inhibitor Nintedanib induces lysosomal dysfunctionality: Role of protonation-dependent crystallization processes

被引:1
|
作者
Mosca, Elena [1 ]
Federa, Anja [2 ,3 ]
Pirker, Christine [1 ]
Schosserer, Markus [4 ]
Liendl, Lisa [5 ]
Eckhard, Margret [14 ]
Sombke, Andy [14 ]
Domotor, Orsolya [7 ]
Kirchhofer, Dominik [1 ]
Timelthaler, Gerald [1 ]
Baier, Dina [1 ,2 ,8 ]
Gurschka, Patrizia [1 ,9 ]
Gabler, Lisa [1 ]
Reithofer, Michael [2 ]
Chin, Jia Min [10 ]
Elsayad, Kareem [6 ]
Englinger, Bernhard [1 ,11 ]
Tahir, Ammar [12 ,13 ]
Kowol, Christian R. [2 ]
Berger, Walter [1 ]
机构
[1] Med Univ Vienna, Ctr Canc Res, Comprehens Canc Ctr, Borschkegasse 8a, A-1090 Vienna, Austria
[2] Univ Vienna, Inst Inorgan Chem, Fac Chem, Wahringer Str 42, A-1090 Vienna, Austria
[3] Univ Vienna, Doctoral Sch Chem DoSChem, Wahringer Str 40-42, A-1090 Vienna, Austria
[4] Med Univ Vienna, Ctr Pathobiochem & Genet, Wahringer Str 10, A-1090 Vienna, Austria
[5] Univ Nat Resources & Life Sci, Inst Mol Biotechnol, Dept Biotechnol, Muthgasse 18, A-1190 Vienna, Austria
[6] Med Univ Vienna, Ctr Anat & Cell Biol, Div Anat, Wahringer Str 13, A-1090 Vienna, Austria
[7] Univ Szeged, Interdisciplinary Excellence Ctr, Dept Mol & Analyt Chem, Dom Ter 7-8, H-6720 Szeged, Hungary
[8] Res Cluster Translat Canc Therapy Res, A-1090 Vienna, Austria
[9] Med Univ Vienna, Dept Neurosurg, Wahringer Gurtel 18-20, A-1090 Vienna, Austria
[10] Dept Funct Mat & Catalysis, Wahringer Str 42, A-1090 Vienna, Austria
[11] Med Univ Vienna, Dept Urol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria
[12] Univ Vienna, Fac Life Sci, Dept Pharmaceut Sci, Div Pharmacognosy, Josef Holaubek Pl 2, A-1090 Vienna, Austria
[13] Univ Appl Sci, Dept Hlth Sci, Sect Biomed Sci, FH Campus Wien, Favoritenstr 226, A-1100 Vienna, Austria
[14] Med Univ Vienna, Ctr Anat & Cell Biol, Cell & Dev Biol, Schwarzspanierstr 17, A-1090 Vienna, Austria
基金
奥地利科学基金会;
关键词
Nintedanib; Fluorescence; Crystallization; Lysosomotropism; Phototoxicity; Phospholipidosis; DRUG-INDUCED PHOSPHOLIPIDOSIS; LIQUID-CRYSTALS; DISCOVERY;
D O I
10.1016/j.cbi.2024.111243
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nintedanib (NIN), a multi-tyrosine kinase inhibitor clinically approved for idiopathic pulmonary fibrosis and lung cancer, is characterized by protonation-dependent lysosomotropic behavior and appearance of lysosomespecific fluorescence emission properties. Here we investigate whether spontaneous formation of a so far unknown NIN matter within the acidic cell compartment is underlying these unexpected emissive properties and investigate the consequences on lysosome functionality. Lysosomes of cells treated with NIN, but not nonprotonatable NIN derivatives, exhibited lysosome-associated birefringence signals co-localizing with the NINderived fluorescence emission. Sensitivity of both parameters towards vATPase inhibitors confirmed pH- dependent, spontaneous adoption of novel crystalline NIN structures in lysosomes. Accordingly, NIN crystallization from buffer solutions resulted in formation of multiple crystal polymorphs with pH-dependent fluorescence properties. Cell-free crystals grown at lysosomal-like pH conditions resembled NIN-treated cell lysosomes concerning fluorescence pattern, photobleaching dynamics, and Raman spectra. However, differences in birefringence intensity and FAIM-determined anisotropy, as well as predominant association with (intra)lysosomal membrane structures, suggested formation of a semi-solid NIN crystalline matter in acidic lysosomes. Despite comparable target kinase inhibition, NIN, but not its non-protonatable derivatives, impaired lysosomal functionality, mediated massive cell vacuolization, enhanced autophagy, deregulated lipid metabolism, and induced atypical phospholipidosis. Moreover, NIN exerted distinct phototoxicity, strictly dependent on lysosomal microcrystallization events. The spontaneous formation of NIN crystalline structures was also observable in the gut mucosa of orally NIN-treated mice. Summarizing, the here-described kinase inhibition-independent impact of NIN on lysosomal functionality mediates several of its cell biological activities and might contribute to NIN adverse effects.
引用
收藏
页数:17
相关论文
共 10 条
  • [1] The tyrosine kinase inhibitor nintedanib activates SHP-1 and induces apoptosis in triple-negative breast cancer cells
    Liu, Chun-Yu
    Huang, Tzu-Ting
    Chu, Pei-Yi
    Huang, Chun-Teng
    Lee, Chia-Han
    Wang, Wan-Lun
    Lau, Ka-Yi
    Tsai, Wen-Chun
    Chao, Tzu-I
    Su, Jung-Chen
    Chen, Ming-Huang
    Shiau, Chung-Wai
    Tseng, Ling-Ming
    Chen, Kuen-Feng
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2017, 49 : e366 - e366
  • [2] The tyrosine kinase inhibitor nintedanib activates SHP-1 and induces apoptosis in triple-negative breast cancer cells
    Chun-Yu Liu
    Tzu-Ting Huang
    Pei-Yi Chu
    Chun-Teng Huang
    Chia-Han Lee
    Wan-Lun Wang
    Ka-Yi Lau
    Wen-Chun Tsai
    Tzu-I Chao
    Jung-Chen Su
    Ming-Huang Chen
    Chung-Wai Shiau
    Ling-Ming Tseng
    Kuen-Feng Chen
    Experimental & Molecular Medicine, 2017, 49 : e366 - e366
  • [3] The Multitargeted Receptor Tyrosine Kinase Inhibitor Linifanib (ABT-869) Induces Apoptosis through an Akt and Glycogen Synthase Kinase 3β-Dependent Pathway
    Hernandez-Davies, Jenny E.
    Zape, Joan P.
    Landaw, Elliot M.
    Tan, Xiaolin
    Presnell, Ajia
    Griffith, Diana
    Heinrich, Michael C.
    Glaser, Keith B.
    Sakamoto, Kathleen M.
    MOLECULAR CANCER THERAPEUTICS, 2011, 10 (06) : 949 - 959
  • [4] The phosphoinositide-dependent protein kinase 1 inhibitor, UCN-01, induces fragmentation: Possible role of metalloproteinases
    Alcantara-Hernandez, Rocio
    Hernandez-Mendez, Aurelio
    Adolfo Garcia-Sainz, J.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 740 : 88 - 96
  • [5] A receptor tyrosine kinase inhibitor, Tyrphostin A9 induces cancer cell death through Drp1 dependent mitochondria fragmentation
    Park, So Jung
    Park, Young Jun
    Shin, Ji Hyun
    Kim, Eun Sung
    Hwang, Jung Jin
    Jin, Dong-Hoon
    Kim, Jin Cheon
    Cho, Dong-Hyung
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 408 (03) : 465 - 470
  • [6] Lapatinib, a HER2 tyrosine kinase inhibitor, induces stabilization and accumulation of HER2 and potentiates trastuzumab-dependent cell cytotoxicity
    Scaltriti, M.
    Verma, C.
    Guzman, M.
    Jimenez, J.
    Parra, J. L.
    Pedersen, K.
    Smith, D. J.
    Landolfi, S.
    Ramon y Cajal, S.
    Arribas, J.
    Baselga, J.
    ONCOGENE, 2009, 28 (06) : 803 - 814
  • [7] Studies on the Role of Metabolic Activation in Tyrosine Kinase Inhibitor-Dependent Hepatotoxicity: Induction of CYP3A4 Enhances the Cytotoxicity of Lapatinib in HepaRG Cells
    Hardy, Klarissa D.
    Wahlin, Michelle D.
    Papageorgiou, Ioannis
    Unadkat, Jashvant D.
    Rettie, Allan E.
    Nelson, Sidney D.
    DRUG METABOLISM AND DISPOSITION, 2014, 42 (01) : 162 - 171
  • [8] BMS-690514, a VEGFR and EGFR tyrosine kinase inhibitor, shows anti-tumoural activity on non-small-cell lung cancer xenografts and induces sequence-dependent synergistic effect with radiation
    Y Loriot
    P Mordant
    N Dorvault
    T De la motte Rouge
    J Bourhis
    J-C Soria
    E Deutsch
    British Journal of Cancer, 2010, 103 : 347 - 353
  • [9] BMS-690514, a VEGFR and EGFR tyrosine kinase inhibitor, shows anti-tumoural activity on non-small-cell lung cancer xenografts and induces sequence-dependent synergistic effect with radiation
    Loriot, Y.
    Mordant, P.
    Dorvault, N.
    Rouge, T. De la Motte
    Bourhis, J.
    Soria, J-C
    Deutsch, E.
    BRITISH JOURNAL OF CANCER, 2010, 103 (03) : 347 - 353
  • [10] The novel tyrosine kinase inhibitor (TKI) exel-0862 potently induces apoptosis in human FlP1L1-PDGFR-α-Expressing cells through caspase-dependent cleavage of MCL-1
    pan, Jing Pan
    Quintas-Cardama, Alfonso
    Kantarjian, Hagop
    Lamb, Peter
    Tefferi, Ayalew
    Cortes, Jorge
    Giles, Francis
    Verstovsek, Srdan
    BLOOD, 2006, 108 (11) : 307B - 307B